The scaffold protein RACK1 mediates the RANKL-dependent activation of p38 MAPK in osteoclast precursors

Science Signaling

Volumn 8, Issue 379, 2015, Pages

  Lin, Jingjing ^a   Lee, Daekee ^a   Choi, Yongwon ^b   Lee, Soo Young ^a  

^a Ewha Womans University   (South Korea)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE P38; MULTIPROTEIN COMPLEX; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR FOR ACTIVATED C KINASE 1; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; CELL SURFACE RECEPTOR; GNB2-RS1 PROTEIN, MOUSE; GNB2L1 PROTEIN, HUMAN; GUANINE NUCLEOTIDE BINDING PROTEIN; NEUROPEPTIDE; TNFSF11 PROTEIN, HUMAN; TNFSF11 PROTEIN, MOUSE; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELETION MUTANT; DENDRITIC CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INDUCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; WILD TYPE; ANIMAL; CYTOLOGY; GENETICS; HEK293 CELL LINE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; STEM CELL;

MUS;

ANIMALS; ENZYME ACTIVATION; GTP-BINDING PROTEINS; HEK293 CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; NEOPLASM PROTEINS; NEUROPEPTIDES; OSTEOCLASTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RANK LIGAND; RECEPTORS, CELL SURFACE; STEM CELLS;

EID: 84930511364     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2005867     Document Type: Article

References (59)

1. J. Lorenzo, M. Horowitz, Y. Choi, Osteoimmunology: Interactions of the bone and immune system. Endocr. Rev. 29, 403-440 (2008).
2. S. L. Teitelbaum, Bone resorption by osteoclasts. Science 289, 1504-1508 (2000).
3. W. J. Boyle, W. S. Simonet, D. L. Lacey, Osteoclast differentiation and activation. Nature 423, 337-342 (2003).
4. T. Suda, N. Takahashi, N. Udagawa, E. Jimi, M. T. Gillespie, T. J. Martin, Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20, 345-357 (1999).
5. B. G. Darnay, A. Besse, A. T. Poblenz, B. Lamothe, J. J. Jacoby, TRAFs in RANK signaling. Adv. Exp. Med. Biol. 597, 152-159 (2007).
6. M. A. Lomaga, W.-C. Yeh, I. Sarosi, G. S. Duncan, C. Furlonger, A. Ho, S. Morony, C. Capparelli, G. Van, S. Kaufman, A. van der Heiden, A. Itie, A. Wakeham, W. Khoo, T. Sasaki, Z. Cao, J. M. Penninger, C. J. Paige, D. L. Lacey, C. R. Dunstan, W. J. Boyle, D. V. Goeddel, T. W. Mak, TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13, 1015-1024 (1999).
7. A. Naito, S. Azuma, S. Tanaka, T. Miyazaki, S. Takaki, K. Takatsu, K. Nakao, K. Nakamura, M. Katsuki, T. Yamamoto, J. Inoue, Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 4, 353-362 (1999).
8. B. Lamothe, W. K. Webster, A. Gopinathan, A. Besse, A. D. Campos, B. G. Darnay, TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation. Biochem. Biophys. Res. Commun. 359, 1044-1049 (2007).
9. J. Mizukami, G. Takaesu, H. Akatsuka, H. Sakurai, J. Ninomiya-Tsuji, K. Matsumoto, N. Sakurai, Receptor activator of NF-κB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6. Mol. Cell. Biol. 22, 992-1000 (2002).
10. S. Sato, H. Sanjo, K. Takeda, J. Ninomiya-Tsuji, M. Yamamoto, T. Kawai, K. Matsumoto, O. Takeuchi, S. Akira, Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6, 1087-1095 (2005).
11. J.-H. Shim, C. Xiao, A. E. Paschal, S. T. Bailey, P. Rao, M. S. Hayden, K.-Y. Lee, C. Bussey, M. Steckel, N. Tanaka, G. Yamada, S. Akira, K. Matsumoto, S. Ghosh, TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 19, 2668-2681 (2005).
12. M. Asagiri, H. Takayanagi, The molecular understanding of osteoclast differentiation. Bone 40, 251-264 (2007).
13. M. Asagiri, K. Sato, T. Usami, S. Ochi, H. Nishina, H. Yoshida, I. Morita, E. F. Wagner, T. W. Mak, E. Serfling, H. Takayanagi, Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp. Med. 202, 1261-1269 (2005).
14. X. Li, N. Udagawa, K. Itoh, K. Suda, Y. Murase, T. Nishihara, T. Suda, N. Takahashi, p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function. Endocrinology 143, 3105-3113 (2002).
15. S. E. Lee, K. M. Woo, S. Y. Kim, H.-M. Kim, K. Kwack, Z. H. Lee, H.-H. Kim, The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone 30, 71-77 (2002).
16. M. Matsumoto, T. Sudo, T. Saito, H. Osada, M. Tsujimoto, Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-κB ligand (RANKL). J. Biol. Chem. 275, 31155-31161 (2000).
17. H. Huang, J. Ryu, J. Ha, E.-J. Chang, H. J. Kim, H.-M. Kim, T. Kitamura, Z. H. Lee, H.-H. Kim, Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-κB transactivation by RANKL. Cell Death Differ. 13, 1879-1891 (2006).
18. A. Thiefes, A. Wolf, A. Doerrie, G. A. Grassl, K. Matsumoto, I. Autenrieth, E. Bohn, H. Sakurai, R. Niedenthal, K. Resch, M. Kracht, The Yersinia enterocolitica effector YopP inhibits host cell signalling by inactivating the protein kinase TAK1 in the IL-1 signalling pathway. EMBO Rep. 7, 838-844 (2006).
19. F. Xiao, H. Wang, X. Fu, Y. Li, Z. Wu, TRAF6 promotes myogenic differentiation via the TAK1/p38 mitogen-activated protein kinase and Akt pathways. PLOS One 7, e34081 (2012).
20. A. McCahill, J. Warwicker, G. B. Bolger, M. D. Houslay, S. J. Yarwood, The RACK1 scaffold protein: A dynamic cog in cell response mechanisms. Mol. Pharmacol. 62, 1261-1273 (2002).
21. D. Ron, C.-H. Chen, J. Caldwell, L. Jamieson, E. Orr, D. Mochly-Rosen, Cloning of an intracellular receptor for protein kinase C: A homolog of the β subunit of G proteins. Proc. Natl. Acad. Sci. U.S.A. 91, 839-843 (1994).
22. V. Mamidipudi, C. A. Cartwright, A novel pro-apoptotic function of RACK1: Suppression of Src activity in the intrinsic and Akt pathways. Oncogene 28, 4421-4433 (2009).
23. R. J. Bird, G. S. Baillie, S. J. Yarwood, Interaction with receptor for activated C-kinase 1 (RACK1) sensitizes the phosphodiesterase PDE4D5 towards hydrolysis of cAMP and activation by protein kinase C. Biochem. J. 432, 207-216 (2010).
24. A. Besson, T. L. Wilson, V. W. Yong, The anchoring protein RACK1 links protein kinase Cε to integrin β chains. Requirements for adhesion and motility. J. Biol. Chem. 277, 22073-22084 (2002).
25. J. Wang, M. F. Lanfranco, S. L. Gibb, Q. V. Yowell, S. Carnicella, D. Ron, Long-lasting adaptations of the NR2B-containing NMDA receptors in the dorsomedial striatum play a crucial role in alcohol consumption and relapse. J. Neurosci. 30, 10187-10198 (2010).
26. P. A. Kiely, A. Sant, R. O'Connor, RACK1 is an insulin-like growth factor 1 (IGF-1) receptor-interacting protein that can regulate IGF-1-mediated Akt activation and protection from cell death. J. Biol. Chem. 277, 22581-22589 (2002).
27. D. R. Adams, D. Ron, P. A. Kiely, RACK1, A multifaceted scaffolding protein: Structure and function. Cell Commun. Signal. 9, 22 (2011).
28. Y. Guo, W. Wang, J. Wang, J. Feng, Q. Wang, J. Jin, M. Lv, X. Li, Y. Li, Y. Ma, B. Shen, J. Zhang, Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen-activated protein kinase kinase 7 activity. Hepatology 57, 140-151 (2013).
29. P. López-Bergami, H. Habelhah, A. Bhoumik, W. Zhang, L.-H. Wang, Z. Ronai, RACK1 mediates activation of JNK by protein kinase C. Mol. Cell 19, 309-320 (2005).
30. T. Vomastek, M. P. Iwanicki, H.-J. Schaeffer, A. Tarcsafalvi, J. T. Parsons, M. J. Weber, RACK1 targets the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway to link integrin engagement with focal adhesion disassembly and cell motility. Mol. Cell. Biol. 27, 8296-8305 (2007).
31. N. Y. Bhatt, T. W. Kelley, V. V. Khramtsov, Y. Wang, G. K. Lam, T. L. Clanton, C. B. Marsh, Macrophage-colony-stimulating factor-induced activation of extracellular-regulated kinase involves phosphatidylinositol 3-kinase and reactive oxygen species in human monocytes. J. Immunol. 169, 6427-6434 (2002).
32. T. Kawai, S. Akira, TLR signaling. Cell Death Differ. 13, 816-825 (2006).
33. C. Gabay, C. Lamacchia, G. Palmer, IL-1 pathways in inflammation and human diseases. Nat. Rev. Rheumatol. 6, 232-241 (2010).
34. S. W. Lee, H. B. Kwak, W. J. Chung, H. Cheong, H.-H. Kim, Z. H. Lee, Participation of protein kinase C b in osteoclast differentiation and function. Bone 32, 217-227 (2003).
35. J. Shin, H. Jang, J. Lin, S. Y. Lee, PKCb positively regulates RANKL-induced osteoclastogenesis by inactivating GSK-3b. Mol. Cells 37, 747-752 (2014).
36. J. Nilsson, J. Sengupta, J. Frank, P. Nissen, Regulation of eukaryotic translation by the RACK1 protein: A platform for signalling molecules on the ribosome. EMBO Rep. 5, 1137-1141 (2004).
37. B. Lamothe, Y. Lai, M. Xie, M. D. Schneider, B. G. Darnay, TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and necroptosis. Mol. Cell. Biol. 33, 582-595 (2013).
38. Y. Kadono, F. Okada, C. Perchonock, H. D. Jang, S. Y. Lee, N. Kim, Y. Choi, Strength of TRAF6 signalling determines osteoclastogenesis. EMBO Rep. 6, 171-176 (2005).
39. C. Wang, L. Deng, M. Hong, G. R. Akkaraju, J. Inoue, Z. J. Chen, TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346-351 (2001).
40. J. Ninomiya-Tsuji, K. Kishimoto, A. Hiyama, J. Inoue, Z. Cao, K. Matsumoto, The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398, 252-256 (1999).
41. K. Kishimoto, K. Matsumoto, J. Ninomiya-Tsuji, TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop. J. Biol. Chem. 275, 7359-7364 (2000).
42. H. Kim, H. K. Choi, J. H. Shin, K. H. Kim, J. Y. Huh, S. A. Lee, C.-Y. Ko, H.-S. Kim, H.-I. Shin, H. J. Lee, D. Jeong, N. Kim, Y. Choi, S. Y. Lee, Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice. J. Clin. Invest. 119, 813-825 (2009).
43. J. S. C. Arthur, S. C. Ley, Mitogen-activated protein kinases in innate immunity. Nat. Rev. Immunol. 13, 679-692 (2013).
44. H. Wu, J. R. Arron, TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology. Bioessays 25, 1096-1105 (2003).
45. A. Cuadrado, A. R. Nebreda, Mechanisms and functions of p38 MAPK signalling. Biochem. J. 429, 403-417 (2010).
46. F. Witzel, L. Maddison, N. Bluthgen, How scaffolds shape MAPK signaling: What we know and opportunities for systems approaches. Front. Physiol. 3, 475 (2012).
47. A. J. Whitmarsh, C.-Y. Kuan, N. J. Kennedy, N. Kelkar, T. F. Haydar, J. P. Mordes, M. Appel, A. A. Rossini, S. N. Jones, R. A. Flavell, P. Rakic, R. J. Davis, Requirement of the JIP1 scaffold protein for stress-induced JNK activation. Genes Dev. 15, 2421-2432 (2001).
48. N. K. Lee, Y. G. Choi, J. Y. Baik, S. Y. Han, D. W. Jeong, Y. S. Bae, N. Kim, S. Y. Lee, A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 106, 852-859 (2005).
49. H. H. Lee, P. W. Dempsey, T. P. Parks, X. Zhu, D. Baltimore, G. Cheng, Specificities of CD40 signaling: Involvement of TRAF2 in CD40-induced NF-κB activation and intercellular adhesion molecule-1 up-regulation. Proc. Natl. Acad. Sci. U.S.A. 96, 1421-1426 (1999).
50. J. Gohda, T. Akiyama, T. Koga, H. Takayanagi, S. Tanaka, J. Inoue, RANK-mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis. EMBO J. 24, 790-799 (2005).
51. J. J. Li, D. Xie, RACK1, a versatile hub in cancer. Oncogene 34, 1890-1898 (2015).
52. D.-S. Choi, H. Young, T. McMahon, D. Wang, R. O. Messing, The mouse RACK1 gene is regulated by nuclear factor-κB and contributes to cell survival. Mol. Pharmacol. 64, 1541-1548 (2003).
53. M. Landström, The TAK1-TRAF6 signalling pathway. Int. J. Biochem. Cell Biol. 42, 585-589 (2010).
54. H. D. Jang, J. H. Shin, D. R. Park, J. H. Hong, K. Yoon, R. Ko, C.-Y. Ko, H. S. Kim, D. Jeong, N. Kim, S. Y. Lee, Inactivation of glycogen synthase kinase-3b is required for osteoclast differentiation. J. Biol. Chem. 286, 39043-39050 (2011).
55. K. Arimoto, H. Fukuda, S. Imajoh-Ohmi, H. Saito, M. Takekawa, Formation of stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways. Nat. Cell Biol. 10, 1324-1332 (2008).
56. M. S. Robles, C. Boyault, D. Knutti, K. Padmanabhan, C. J. Weitz, Identification of RACK1 and protein kinase Ca as integral components of the mammalian circadian clock. Science 327, 463-466 (2010).
57. S. Morioka, M. Inagaki, Y. Komatsu, Y. Mishina, K. Matsumoto, J. Ninomiya-Tsuji, TAK1 kinase signaling regulates embryonic angiogenesis by modulating endothelial cell survival and migration. Blood 120, 3846-3857 (2012).
58. H. K. Choi, H. R. Kang, E. Jung, T. E. Kim, J. J. Lin, S. Y. Lee, Early estrogen-induced gene 1, a novel RANK signaling component, is essential for osteoclastogenesis. Cell Res. 23, 524-536 (2013).
59. E. K. Schmidt, G. Clavarino, M. Ceppi, P. Pierre, SUnSET, a nonradioactive method to monitor protein synthesis. Nat. Methods 6, 275-277 (2009).